02506nam 2200457 450 991013834880332120240125190729.0953-51-6885-1(CKB)3230000000075551(NjHacI)993230000000075551(oapen)https://directory.doabooks.org/handle/20.500.12854/65772(EXLCZ)99323000000007555120221010d2012 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierAntiviral drugs aspects of clinical use and recent advances /edited by Patrick ArbuthnotIntechOpen2012[Place of publication not identified] :InTech,[2012]©20121 online resource (208 pages) illustrations953-51-0256-7 Includes bibliographical references.The articles that appear in Antiviral Drugs - Aspects of Clinical Use and Recent Advances cover several topics that reflect the varied mechanisms of viral disease pathogenesis and treatment. Clinical management and new developments in the treatment of virus-related diseases are the two main sections of the book. The first part reviews the treatment of hepatitis C virus infection, the management of virus-related acute retinal necrosis, the use of leflunomide therapy in renal transplant patients, and mathematical modeling of HIV-1 treatment responses. Basic research topics are dealt with in the second half of the book. New developments in the treatment of the influenza virus, the use of animal models for HIV-1 drug development, the use of single chain camelid antibodies against negative strand RNA viruses, countering norovirus infection, and the use of plant extracts to treat herpes simplex virus infection are described. The content of the book is not intended to be comprehensive, but aims to provide the reader with insights into selected aspects of established and new viral therapies.Antiviral drugsAntiviral agentsVirus diseasesChemotherapyPharmacologyAntiviral agents.Virus diseasesChemotherapy.616.925061Arbuthnot Patrickedt1466719Arbuthnot PatrickNjHacINjHaclBOOK9910138348803321Antiviral drugs3870880UNINA